Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Education Health & Fitness

Episodes

Showing 1-100 of 113
Page 1 of 2 Next → »»

CAUGHT-CAD: Combining Coronary Calcium Score with Treatment on Plaque Progression in Familial CAD

20 Jan 2026

Contributed by Lukas

Coronary artery calcium (CAC) scoring provides important prognostic value, particularly for individuals at intermediate risk for coronary artery dise...

AI-Enabled Nationwide Opportunistic Screening of Non-Contrast Chest CT for Death and CV Outcomes

13 Jan 2026

Contributed by Lukas

AI technology transforms routine chest computed tomography (CT) scans by precisely quantifying—rather than simply detecting—key cardiovascular im...

ACCEL Lite: Should There Be a Reappraisal of Surgical Threshold in Patients with AA Dilation?

06 Jan 2026

Contributed by Lukas

Ascending aortopathy (AA) is typically asymptomatic and often diagnosed incidentally, with surgical aortic replacement recommended once aneurysmal ...

Top Takeaways from 2025: Preventive Cardiology with C. Noel Bairey Merz, MD, MACC

18 Dec 2025

Contributed by Lukas

In this interview, C. Noel Bairey Merz MD, MACC and Alison L. Bailey, MD FACC, discuss the Top Preventive Cardiology Takeaways from 2025 including ...

Top Takeaways from 2025: EP with DJ Lakkireddy, MBBS, FACC

17 Dec 2025

Contributed by Lukas

In this interview, DJ Lakkireddy, MBBS, FACC and Alison L. Bailey, MD FACC, discuss the Top Electrophysiology Takeaways from 2025 including trials C...

Multimodality Imaging in Inflammatory Cardiomyopathy

16 Dec 2025

Contributed by Lukas

Multimodality imaging plays a pivotal role in evaluating inflammatory cardiomyopathy, particularly when cardiac sarcoidosis (CS) is suspected. Sympt...

Top Takeaways from 2025: Clinical Cardiology with Allen J. Taylor, MD, FACC

11 Dec 2025

Contributed by Lukas

In this interview, Allen J. Taylor, MD, FACC and Alison L. Bailey, MD FACC, discuss the Top Clinical Cardiology Takeaways from 2025 including trials ...

Top Takeaways from 2025: Interventional Cardiology with Deepak Bhatt, MD, MPH, MBA, FACC

10 Dec 2025

Contributed by Lukas

In this interview, Deepak Bhatt, MD, MPH, FACC and Alison L. Bailey, MD FACC, discuss the Top Interventional Cardiology Takeaways from 2025 including...

PANTHER-P2Y12 Inhibitor or Aspirin moNoTHERapy as Secondary Prevention in Patients with CAD

09 Dec 2025

Contributed by Lukas

he PANTHER study indicates that clopidogrel provides superior protection against major cardiovascular events compared to aspirin in patients with ...

ACCEL Lite: Top Takeaways from 2025: HF with Clyde Yancy MD, MSc, MACC

04 Dec 2025

Contributed by Lukas

In this interview, Clyde Yancy MD, MSc, MACC and Alison L. Bailey, MD FACC, discuss the Top Heart Failure Takeaways from 2025 including trials SUMMIT...

ACCEL Lite: Top Takeaways from 2025: CV Imaging with Amit R. Patel, MD, FACC

03 Dec 2025

Contributed by Lukas

In this interview, Amit R. Patel, MD, FACC and Alison L. Bailey, MD FACC, discuss the Top Cardiovascular Imaging Takeaways from 2025 including myocar...

C-Reactive Protein and CV Risk in the General Population

02 Dec 2025

Contributed by Lukas

Inflammation is a key contributor to cardiovascular disease (CVD), influencing both its onset and progression. High-sensitivity C-reactive protein (h...

ALONE-AF: Discontinuing Long-Term Oral Anticoagulation After Successful AFib Ablation

25 Nov 2025

Contributed by Lukas

The ALONE-AF study examined outcomes in atrial fibrillation (AF) patients who remained free of recurrence following catheter ablation. Researchers fo...

How Does Imaging Guide Management in Patients with Obesity?

18 Nov 2025

Contributed by Lukas

Imaging is a powerful tool in managing obesity, helping clinicians visualize fat distribution and detect complications like fatty liver disease or he...

TACSI Trial: Dual or Single Antiplatelet Therapy After CABG in Patients With ACS

11 Nov 2025

Contributed by Lukas

In the TACSI trial, researchers evaluated ticagrelor plus aspirin versus aspirin alone in about 2,200 patients who underwent coronary artery bypass g...

VICTORION-Difference: Inclisiran-Based Strategy vs. Standard of Care

04 Nov 2025

Contributed by Lukas

Current clinical challenges in lipid control include achieving and maintaining target LDL-cholesterol levels in patients at high risk for atheros...

Aortopathies: What A Cardiologist Needs to Know

28 Oct 2025

Contributed by Lukas

What if your genes could predict a life-threatening condition before symptoms ever appear? Explore how medical science uncovered the genetic roots of...

PhysioSync-HF: Conduction System vs. Biventricular Pacing in Cardiac Resynchronization in HFrEF

21 Oct 2025

Contributed by Lukas

Can a newer, more targeted pacing method revolutionize heart failure treatment? The PhysioSync-HF trial investigates conduction system pacing as a ...

DAPT-SHOCK-AMI Trial: Cangrelor in Cardiogenic Shock

14 Oct 2025

Contributed by Lukas

The DAPT SHOCK AMI trial is the first major study to evaluate antiplatelet therapy specifically in patients with cardiogenic shock (CS) following acu...

ODYSSEY-HCM: Mavacamten in nHCM

07 Oct 2025

Contributed by Lukas

The ODYSSEY-HCM trial found that mavacamten did not significantly improve exercise capacity or patient-reported outcomes in individuals with symptoma...

DAN-RSV: RSVpreF Vaccine for Preventing Cardiorespiratory Hospitalizations

30 Sep 2025

Contributed by Lukas

The DAN-RSV trial is one of the largest individually randomized studies ever conducted, enrolling over 131,000 participants aged 60 and older to eval...

The Role of Prevention During and After Reproduction

23 Sep 2025

Contributed by Lukas

Adverse pregnancy outcomes (APOs), affecting up to 20% of pregnancies, serve as early indicators of a woman's future cardiovascular risk and should b...

The Role of Imaging in Cardiovascular Prevention

16 Sep 2025

Contributed by Lukas

Cohort studies have provided robust data on cardiovascular risk factors, forming the basis for predictive models like the Pooled Cohort Equations and...

Improving Cardiovascular Clinical Competencies Menopausal Transition

09 Sep 2025

Contributed by Lukas

The menopause transition marks a pivotal period of cardiometabolic change that significantly elevates cardiovascular (CV) risk in women. Despite its ...

Behind the 2025 ACC/AHA Acute Coronary Syndrome Guideline

02 Sep 2025

Contributed by Lukas

The 2025 ACC/AHA Acute Coronary Syndrome guideline is the first major update since 2013, incorporating a decade of new evidence and clinical insights...

Top Takeaways From the 2025 ACC/AHA Acute Coronary Syndrome Guideline

26 Aug 2025

Contributed by Lukas

The 2025 ACC/AHA Acute Coronary Syndrome (ACS) Guideline clarifies diagnostic distinctions using electrocardiogram changes, troponin levels, and imag...

Risk vs. Benefit in Chronic Total Occlusion Revascularization

19 Aug 2025

Contributed by Lukas

Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI) is a procedure used to open coronary arteries that have been completely blocked ...

LAAO vs. DOAC for Stroke Prevention in AFib

12 Aug 2025

Contributed by Lukas

While blood thinners like warfarin and direct oral anticoagulants (DOACs) remain the standard for stroke prophylaxis, left atrial appendage occlusion...

Why Are They Still Dyspneic? Post PE Syndrome Workup and Management

05 Aug 2025

Contributed by Lukas

Persistent symptoms after an acute pulmonary embolism (PE) may indicate post-pulmonary embolism syndrome (PPES), a condition affecting up to 50% of p...

Palliative Care Across the Spectrum of Biological Age in Heart Failure

29 Jul 2025

Contributed by Lukas

Palliative care supports heart failure patients by guiding complex medical decisions, managing symptoms, and enhancing quality of life. Despite being...

ACCEL Lite: Hypertension Diagnosis and Management: Renal Denervation and Newer Agents on the Horizon

22 Jul 2025

Contributed by Lukas

Recent clinical trials demonstrate that intensive blood pressure lowering—targeting systolic levels below 120 mm Hg—can significantly reduce card...

What's the Best Time to Revascularize the Non-culprit Lesions in MVD

15 Jul 2025

Contributed by Lukas

Rapid emergency medical services transport to a percutaneous coronary intervention (PCI)-capable hospital is critical for timely intervention and man...

Putting it All Together: Cardiogenic Shock Management in 2025

08 Jul 2025

Contributed by Lukas

Cardiogenic shock remains a critical, time-sensitive emergency with a high mortality rate. However, recent advances—particularly multidisciplinary,...

Hemodynamic Assessment for Diagnosis and Treatment Selection in HFpEF

01 Jul 2025

Contributed by Lukas

Heart failure arises when the heart is unable to pump or fill with blood effectively. In the cardiac catheterization lab, we have the unique ability ...

Primary Results From the SOUL Randomized Trial

24 Jun 2025

Contributed by Lukas

The SOUL trial demonstrated that in patients with type 2 diabetes (T2DM) and established atherosclerotic cardiovascular disease (ASCVD), chronic kidn...

Clopidogrel Versus Aspirin For Long-term Maintenance Monotherapy In Patients With High Ischemic Risk After PCI

17 Jun 2025

Contributed by Lukas

The SMART-CHOICE 3 trial demonstrated that clopidogrel monotherapy is more effective than aspirin monotherapy in reducing the risk of major adverse c...

Dapagliflozin in Patients Undergoing Transcatheter Aortic Valve Implantation

10 Jun 2025

Contributed by Lukas

The DapaTAVI trial, conducted across 39 centers in Spain, is the first study to evaluate the use of sodium-glucose co-transporter-2 (SGLT-2) inhibit...

PRAGUE-25 Trial: Catheter Ablation Versus Antiarrhythmic Drugs With Risk Factor Modification for Treatment of AF

03 Jun 2025

Contributed by Lukas

The PRAGUE-25 study evaluated the effectiveness of two treatment strategies in patients with both atrial fibrillation (AF) and obesity: catheter abl...

Lifetime Benefit by Control of Modifiable Risk Factors

27 May 2025

Contributed by Lukas

A Global Cardiovascular Risk Consortium study of nearly 2 million people worldwide found that avoiding five modifiable risk factors—hypertension, h...

ZENITH Phase 3 Trial: Sotatercept in Pulmonary Arterial Hypertension With High Mortality Risk

20 May 2025

Contributed by Lukas

The ZENITH trial evaluated sotatercept, an activin signaling inhibitor, in patients with advanced pulmonary arterial hypertension (PAH) at high risk ...

Cardiac Arrest During Long-Distance Running Races: 2010-2023

13 May 2025

Contributed by Lukas

The "Cardiac Arrest During Long-Distance Running Races: 2010–2023" study analyzed the incidence and outcomes of sudden cardiac arrests (SCAs) occur...

WARRIOR Trial: Outcomes to Reduce Events in Non-Obstructive Coronary Artery Disease

06 May 2025

Contributed by Lukas

Funded by the Congressionally Directed Medical Research Programs (CDMRP) of the Department of Defense, the WARRIOR (Women's IschemiA TRial to Reduce ...

STRIDE Trial: Effects of Semaglutide in Patients With Peripheral Artery Disease

29 Apr 2025

Contributed by Lukas

Patients with peripheral artery disease (PAD) often experience significant walking difficulties, and there are limited therapies available to improve...

Evolut Low-Risk Trial: 5-year Data Outcomes

22 Apr 2025

Contributed by Lukas

Transcatheter aortic valve replacement (TAVR) has emerged as the preferred treatment for aortic stenosis. However, there is a lack of long-term outco...

FRESH-UP Study: Liberal Fluid Intake Versus Fluid Restriction in Chronic Heart Failure

15 Apr 2025

Contributed by Lukas

Fluid restriction is often recommended for heart failure (HF) patients to prevent congestion, but its benefits and safety are unclear. The FRESH-UP s...

Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Procedures or Pills?

08 Apr 2025

Contributed by Lukas

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and potentially fatal form of elevated blood pressure in the lungs. CTEPH treatment o...

A Look at The 2024 AHA/ACC Perioperative Guideline s

01 Apr 2025

Contributed by Lukas

The 2024 American Heart Association/American College of Cardiology (AHA/ACC)/multisociety guideline for perioperative cardiovascular (CV) management ...

The Evolving Therapeutic Landscape in Obesity and the Effect on CV Outcomes

25 Mar 2025

Contributed by Lukas

In this interview, Drs. Richard Chazal and Mikhail Kosiborod explore the rapidly evolving therapeutic landscape of obesity, with a particular focus o...

Getting the Most Out of ChatGPT and Other Large Language Models in Cardiology

18 Mar 2025

Contributed by Lukas

Drafting messages, summarizing charts, managing appointments, and assessing eligibility are all tasks that large language models can streamline. Howe...

How Low and How Fast Should We Go with LDL Cholesterol?

11 Mar 2025

Contributed by Lukas

A personalized approach to lowering cholesterol is crucial in preventing heart attacks, as the optimal level, speed, and duration of low-density lipo...

Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs To Improve Statin Rates

04 Mar 2025

Contributed by Lukas

Notifying patients and their clinicians about incidental coronary calcium findings can encourage shared decision-making on preventive therapies and s...

Pulmonary Hypertension Associated with Left Heart Disease: Clinical Presentations, Implications for the RV and Treatment Target

25 Feb 2025

Contributed by Lukas

Pulmonary hypertension (PH) is most commonly linked to left heart disease (LHD). The 7th World Symposium on Pulmonary Hypertension PH-LHD task force ...

Cardiovascular Health, CKM Syndrome and CVD Risk: Putting It All Together

18 Feb 2025

Contributed by Lukas

Three complementary constructs  ̶  cardiovascular health, cardiovascular-kidney-metabolic (CKM) syndrome, and cardiovascular disease (CVD) risk...

Artificial Intelligence-based Automated ECHOcardiographic Measurements and the Workflow of Sonographers (AI-ECHO): Randomized Crossover Trial

11 Feb 2025

Contributed by Lukas

The use of artificial intelligence (AI) assistance in echocardiography is proving beneficial in a multitude of ways: significantly reducing time per ...

Implications for Ablation Outcomes: Results from the ARREST-AF Trial

04 Feb 2025

Contributed by Lukas

In this episode, Drs. Joseph Marine and Rajeev Pathak dive into the ARREST-AF trial and its implications for ablation outcomes in atrial fibrillation...

Tools of the Trade for HCM: Update in Diagnosis and Management Strategies of a Common Cardiomyopathy

28 Jan 2025

Contributed by Lukas

Hypertrophic cardiomyopathy (HCM) is generally an inherited global heart disease in which only a fraction of those with the condition are clinically ...

The Role of Advanced Lipid Testing in 2024

21 Jan 2025

Contributed by Lukas

Advanced lipid testing holds significant potential in cardiovascular care by enhancing risk prediction beyond standard lipid panels. For patients, th...

SUMMIT Trial: Tirzepatide for Heart Failure, Preserved Ejection Fraction and Obesity

14 Jan 2025

Contributed by Lukas

he SUMMIT trial compared the safety and efficacy of tirzepatide among patients with heart failure with preserved ejection fraction (HFpEF) and obesit...

Geographic Disparities in Access to Cardiologists in the United States

07 Jan 2025

Contributed by Lukas

Nearly one-half of US counties have no practicing cardiologists. These counties with limited access to cardiovascular care tend to be more rural and ...

Top Takeaways from 2024: EP with Dhanunjaya Lakkireddy, MD, MBA, FACC

19 Dec 2024

Contributed by Lukas

In this interview, Dhanunjaya Lakkireddy, MD, MBA, FACC, and Alison L. Bailey, MD FACC, discuss the Top Electrophysiology (EP) Takeaways from 2024. D...

Top Takeaways from 2024: General Cardiology with Andrew M. Kates, MD, FACC

17 Dec 2024

Contributed by Lukas

In this interview, Andrew M. Kates, MD, FACC, and Alison L. Bailey, MD FACC, discuss the Top General CardiologyTakeaways from 2024. Dr. Kates discuss...

Top Takeaways from 2024: Heart Failure with Clyde W. Yancy, MD, MACC

12 Dec 2024

Contributed by Lukas

In this interview, Clyde W. Yancy, MD, MACC, and Alison L. Bailey, MD FACC, discuss the Top Heart Failure Takeaways from 2024. Dr. Yancy discusses th...

Top Takeaways from 2024: Preventive Cardiology with Noel Bairey Merz, MD, FACC

10 Dec 2024

Contributed by Lukas

In this interview, Noel Bairey Merz, MD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Preventive Cardiology Takeaways from 2024. Dr. Bairey M...

Top Takeaways from 2024: Interventional Cardiology with Deepak L. Bhatt, MD, MPH, MBA, FACC

03 Dec 2024

Contributed by Lukas

In this interview, Deepak L Bhatt, MD, MPH, MBA, FACC, and Alison L. Bailey, MD FACC, discuss the Top Interventional Takeaways from 2024. Dr. Bhatt d...

Top Takeaways from 2024: CV Imaging with Thomas H. Marwick, MD, PhD, FACC

27 Nov 2024

Contributed by Lukas

In this interview, Thomas H. Marwick, MD, PhD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Takeaways from 2024 in Cardiovascular (CV) Imagin...

Key Messages from the ACC Board of Trustees Health Equity Action Plan

19 Nov 2024

Contributed by Lukas

Disparities in health care disproportionally impact under-resourced and minority communities resulting in excess mortality and morbidity. Decreasing ...

How Has Antithrombotic Therapy for PAD Changed Over the Last Decade?

12 Nov 2024

Contributed by Lukas

Medical therapy is critical in preventing the worst complications of peripheral artery disease (PAD), among them heart attack, stroke, bleeding risk,...

What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?

05 Nov 2024

Contributed by Lukas

Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of te...

What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?

05 Nov 2024

Contributed by Lukas

Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of te...

Real-time AI to Influence Clinical Decisions and Practice Towards Evidence-based Care: RAPIDxAI Trial

29 Oct 2024

Contributed by Lukas

Can algorithms improve the management of patients with myocardial injury? Is there a tool to aid diagnosing patients faster and more accurately leadi...

Effect of Antihypertensive Timing on Mortality and Morbidity: BedMed and BedMed-Frail Trials

22 Oct 2024

Contributed by Lukas

The BedMed and BedMed-Frail trials assisted in providing clarity as to the daily timing of prescribed blood pressure medication. The two trials, one ...

Effect of Antihypertensive Timing on Mortality and Morbidity: BedMed and BedMed-Frail Trials

22 Oct 2024

Contributed by Lukas

The BedMed and BedMed-Frail trials assisted in providing clarity as to the daily timing of prescribed blood pressure medication. The two trials, one ...

Potassium Supplementation and the Prevention of Afib After Cardiac Surgery: TiGHT-K Trial

15 Oct 2024

Contributed by Lukas

The goal of the TIGHT K trial was to evaluate if prescribing relaxed control of potassium levels and only giving supplements in the rare event that l...

Older Patients With NSTEMI Randomized Interventional Treatment: SENIOR-RITA Trial

08 Oct 2024

Contributed by Lukas

The goal of the SENIOR RITA trial was to evaluate routine invasive therapy compared with conservative therapy among older patients with non–ST-elev...

Fasting or No Fasting Before Cardiac Catheterization Procedures: SCOFF Trial

01 Oct 2024

Contributed by Lukas

Fasting is a routine part of preparing for a heart procedure. Research found through the SCOFF trial suggests that for certain procedures, removing t...

Percutaneous Repair of Moderate-to-Severe or Severe Functional Mitral Regurgitation in Symptomatic Heart Failure Patients: RESHAPE-HF2 Trial

24 Sep 2024

Contributed by Lukas

The RESHAPE-HF2 (Randomized Investigation of the MitraClip Device in Heart Failure [HF]: Second Trial in Patients With Clinically Significant Functio...

Beta Blocker Interruption in Patients With Prior MI: ABYSS Trial Results

17 Sep 2024

Contributed by Lukas

The goal of the ABYSS (Assessment of Beta-Blocker Interruption 1 Year After an Uncomplicated Myocardial Infarction on Safety and Symptomatic Cardiac ...

Dr. Jim Januzzi talks with Guideline Author Dr. Lynne Stevenson About "Heart Failure" and "Heart Success"

10 Sep 2024

Contributed by Lukas

It is imperative that clinicians understand the differences in each patient and how effective therapies must be individualized and often combined to...

Low Flow-Low Gradient AS in Patients With HF

03 Sep 2024

Contributed by Lukas

In this interview, Vidhu Anand, MD, FACC, and Alison L. Bailey, MD, FACC, provide a comprehensive exploration of Low Flow-Low Gradient Aortic Stenosi...

Not the Same Old 5 Medications: Contemporary GDMT Algorithm in the Post-MI Patient

27 Aug 2024

Contributed by Lukas

With EMPACT-MI being presented at ACC, the definitive study of an additional agent (empagliflozin) will allow for a great discussion on options for p...

What Should I Do About an Elevated Lp(a) Based on Current Evidence and Available Treatments?

20 Aug 2024

Contributed by Lukas

High levels of Lp(a) impact approximately 1 in 5 individuals globally, signaling an elevated risk of heart attacks, strokes, and valve disease. How s...

Undifferentiated Left Ventricular Hypertrophy: Pitfalls in the Diagnosis of HCM

13 Aug 2024

Contributed by Lukas

Understanding the etiology of left ventricular hypertrophy is increasingly important due to the increasing number of targeted therapies coming online...

The Feel Trial: Spirituality Intervention on Blood Pressure Control, Central Hemodynamics and Endothelial Function

06 Aug 2024

Contributed by Lukas

Incorporating spiritual evaluation into medical science is worth consideration. The presence of edifying emotions can potentially yield positive effe...

Eat Food, Not Too Much, Mostly Plants: Nutrition and CVD

23 Jul 2024

Contributed by Lukas

If there were a pill that could lower blood pressure, lower LDL cholesterol, improve erectile function and lower cardiovascular risk, would you take ...

Hypertrophic Cardiomyopathy (HCM): Selecting the Right Meds and Procedures

16 Jul 2024

Contributed by Lukas

Hypertrophic cardiomyopathy (HOCM) often goes unnoticed, yet as awareness grows, patients may find themselves more symptomatic than expected. How do ...

Hypertrophic Cardiomyopathy (HCM): Selecting the Right Meds and Procedures

16 Jul 2024

Contributed by Lukas

Hypertrophic cardiomyopathy (HOCM) often goes unnoticed, yet as awareness grows, patients may find themselves more symptomatic than expected. How do ...

PVC Burden and Its Temporal Variability: 24/48 Hours or Longer Monitoring?

09 Jul 2024

Contributed by Lukas

Premature ventricular contractions (PVCs), commonly experienced as palpitations from occasional skipped heartbeats, are typically benign but can esca...

Financial Incentives to Improve Cardiac Rehab Participation

02 Jul 2024

Contributed by Lukas

Individuals from lower socioeconomic status (SES) backgrounds face heightened risks of morbidity and mortality, particularly in the context of health...

Inpatient Initiation of HF GDMT: What Are You Waiting For?

25 Jun 2024

Contributed by Lukas

In this interview, Stephen Greene, MD, FACC and Sidney C. Smith Jr., MD, MACC discuss inpatient initiation of HF GDMT.    Subscribe on Apple Podc...

Plaque Burden, Morphology and Flow – Beyond the Lumen

18 Jun 2024

Contributed by Lukas

Why should we assess plaque burden beyond luminal narrowing for cardiac prevention?    In this interview, Andrew Choi, MD, FACC and Clyde W. Yan...

Plaque Burden, Morphology and Flow – Beyond the Lumen

18 Jun 2024

Contributed by Lukas

Why should we assess plaque burden beyond luminal narrowing for cardiac prevention?    In this interview, Andrew Choi, MD, FACC and Clyde W. Yan...

Natural History of Bicuspid and Aneurysm-Associated Aortic Valve Disease

11 Jun 2024

Contributed by Lukas

The most common congenital heart defect, congenital BAV, affects 1% of the population (2% in men, 0.5% in women), with a male-to-female ratio of 2:1 ...

Hey Doc, There's Calcium In My Coronaries⋯ Now What?

04 Jun 2024

Contributed by Lukas

Discover how detection of coronary artery calcium can greatly enhance risk prediction and risk mitigation, making it a critical tool for clinicians a...

The Hormone Puzzle: Decoding the what, when and how long of hormone replacement therapy in women

28 May 2024

Contributed by Lukas

In this interview, Leslie Cho, MD, FACC, and Steven E. Nissen MD, MACC explore the nuances of estrogen and testosterone replacement: who benefits, wh...

Ultimate DAPT Trial Principal Results - Ticagrelor monotherapy following one month of dual antiplatelet therapy (DAPT) outperforms 12-month DAPT (aspirin and ticagrelor) post PCI for reducing clinically meaningful bleeding

21 May 2024

Contributed by Lukas

Ticagrelor monotherapy following one month of dual antiplatelet therapy (DAPT) outperforms 12-month DAPT (aspirin and ticagrelor) post PCI for reducin...

Be Active RCT: Gamification & Financial Incentives to Increase Physical Activity

14 May 2024

Contributed by Lukas

The Be Active trial demonstrates the efficacy of scalable interventions, incorporating remote monitoring and behavioral economics, in boosting physic...

Statin Intolerance, Inclisarin, and the VICTORION-INITIATE Trial

07 May 2024

Contributed by Lukas

The VICTORION-INIATATE study demonstrated that initiating inclisiran, a highly potent lipid-lowering therapy, upon failure to achieve lipid targets w...

ARISE-HF Primary Results: Selective Aldose Reductase Inhibitor For Diabetic Cardiomyopathy

23 Apr 2024

Contributed by Lukas

Heart failure is an increasingly recognized complication in chronic diabetes that may be caused by a number of processes including direct effects of ...

The Future of Cardiology - Value-Based Care, Private Equity and the Practice Landscape

16 Apr 2024

Contributed by Lukas

It's becoming increasingly evident that alongside top-notch clinical expertise, the CV specialist of the future must be surrounded by a multi-talente...

EMPACT-MI Results: Empagliflozin After Acute Myocardial Infarction

09 Apr 2024

Contributed by Lukas

Patients with acute myocardial infarction are at a high risk of heart failure and death. Despite advances in care and reduction in the rate of recurr...

Page 1 of 2 Next → »»